News Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-15 pm EST			5-day change	1st Jan Change
268.94 ^USD	+0.69%		+1.79%	+3.18%

Jan. 14	Amgen Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:00 PM
Jan. 10	Wells Fargo Cuts Price Target on Amgen to $280 From $335, Maintains Equalweight Rating	MT

Amgen : 43rd Annual JP Morgan Healthcare Conference Presentation	Jan. 13	PU
Amgen Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:00 PM	Jan. 13
Wells Fargo Cuts Price Target on Amgen to $280 From $335, Maintains Equalweight Rating	Jan. 10	MT
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	Jan. 08	PR
Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating	Jan. 08	MT
Asher Bio Announces Clinical Trial Collaboration and Supply Agreement with Amgen on Etakafusp Alfa in Combination with Bispecific T-cell Engager in Patients with Small Cell Lung Cancer	Jan. 08	CI
Truist Lowers Price Target on Amgen to $298 From $333, Keeps Hold Rating	Jan. 08	MT
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update	Jan. 07	AQ
RBC Trims Price Target on Amgen to $324 From $330, Keeps Outperform Rating	Jan. 07	MT
Amgen?s IMDYLLTRA Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom	Jan. 06	CI
European Equities Close Mostly Higher in Tuesday Trading; EU Withholds Over $1 Billion From Hungary	Dec. 31	MT
Amgen's Tarlatamab Approved by UK Regulator to Treat Lung Cancer	Dec. 31	MT
Sector Update: Health Care Stocks Advance Late Afternoon	Dec. 23	MT
Sector Update: Health Care	Dec. 23	MT
Eli Lilly, Amgen Sue HHS for Unlawful Certifications of Drug Discount Program Recipients	Dec. 23	MT
Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients	Dec. 23	MT
Top Midday Stories: Novo Nordisk Shares Drop After Obesity Treatment Falls Short of Expectations; CFPB Sues 3 Big Banks Over Alleged Zelle Fraud	Dec. 20	MT
Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations	Dec. 20	MT
Jefferies Adjusts Amgen Price Target to $350 From $380, Maintains Buy Rating	Dec. 19	MT
Merck Strikes Deal With China's Hansoh Pharma to Develop Weight Loss Drug	Dec. 18	MT
Akari Therapeutics, plc Announces Board Changes	Dec. 18	CI
UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating	Dec. 17	MT
Amgen's Nobel Laureate Network: A Catalyst for Innovation	Dec. 11	PU
Amgen Boosts Quarterly Dividend by Nearly 6%	Dec. 10	DJ
Amgen Increases Quarterly Dividend to $2.38, Payable March 7 to Shareholders of Record Feb. 14	Dec. 10	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters